Evidence-Based Health Policy—Lessons from the Global Burden of Disease Study

  • Christopher J. L. Murray
    C. J. L. Murray is an associate professor at the Burden of Disease Unit of the Harvard School of Public Health, 9 Bow Street, Cambridge, MA 02138, USA.
  • Alan D. Lopez
    A. D. Lopez is a scientist at the World Health Organization, Geneva CH-1211, Switzerland. The authors alone are responsible for the views expressed here.

抄録

<jats:p>The Global Burden of Disease Study, a comprehensive regional and global assessment of mortality and disability from 107 diseases and injuries and 10 risk factors, is an example of an evidence-based input to public health policy debate. The study, which includes projections of the burden through the year 2020, uses the disability-adjusted life year as a composite measure of years of life lost due to premature mortality and years lived with disability. Future patterns of death and disability are likely to change dramatically because of aging of the world's population, the epidemic of tobacco-related disease, the human immunodeficiency virus epidemic, and the likely reduction in death rates from communicable diseases in children.</jats:p>

収録刊行物

  • Science

    Science 274 (5288), 740-743, 1996-11

    American Association for the Advancement of Science (AAAS)

被引用文献 (43)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ